PIMECROLIMUS for Neurodermatitis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where PIMECROLIMUS was used for Neurodermatitis.
Most Reported Side Effects for PIMECROLIMUS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 349 | 26.3% | 0 | 16 |
| Treatment failure | 139 | 10.5% | 0 | 0 |
| Psoriasis | 114 | 8.6% | 0 | 9 |
| Off label use | 113 | 8.5% | 0 | 2 |
| Pruritus | 94 | 7.1% | 0 | 4 |
| Erythema | 89 | 6.7% | 0 | 4 |
| Product use in unapproved indication | 86 | 6.5% | 1 | 1 |
| Rash | 82 | 6.2% | 0 | 4 |
| Application site pain | 72 | 5.4% | 0 | 2 |
| Therapeutic product effect incomplete | 65 | 4.9% | 0 | 3 |
| Condition aggravated | 59 | 4.5% | 0 | 5 |
| Drug ineffective for unapproved indication | 55 | 4.1% | 0 | 0 |
| Eczema | 52 | 3.9% | 0 | 5 |
| Skin exfoliation | 48 | 3.6% | 0 | 3 |
| Application site erythema | 41 | 3.1% | 0 | 1 |
Other Indications for PIMECROLIMUS
Product used for unknown indication (354)
Psoriasis (217)
Eczema (148)
Dermatitis atopic (103)
Dermatitis (55)
Rash (52)
Rosacea (46)
Product use in unapproved indication (40)
Pruritus (28)
Dermatitis contact (20)
Other Drugs Used for Neurodermatitis
DUPILUMAB (9,956)
NEMOLIZUMAB-ILTO (1,765)
NEMOLIZUMAB (160)
THALIDOMIDE (149)
UPADACITINIB (73)
METHOTREXATE (69)
TRALOKINUMAB-LDRM (46)
CYCLOSPORINE (38)
CRISABOROLE (34)
ABROCITINIB (27)